New Drugs for Neglected Diseases: From Pipeline to Patients

by Pécoul BPLoS Med, October 2004, 1(1):e6. Epub 2004 Oct 19.

Summary: In wealthy countries,state-funded research has yielded breakthroughs in molecular biology,chemistry,and engineering.These advances have been taken up by the pharmaceutical industry and applied to drug development for a growing range of illnesses and conditions.As a result, patients have access to new drugs that are better tolerated, more specific,and more effective than old ones.

Click here to download the full article [PDF]